DK1328289T3 - Oxidized proteins and their biological and therapeutic activity as well as diagnostic use in inhibiting interaction between oxidized proteins and CD36 - Google Patents

Oxidized proteins and their biological and therapeutic activity as well as diagnostic use in inhibiting interaction between oxidized proteins and CD36

Info

Publication number: DK1328289T3
Authority: DK; Denmark
Prior art keywords: oxidized proteins; biological; well; therapeutic activity; diagnostic use
Prior art date: 2000-10-20

Application number

DK01983562T

Other languages

Danish (da)

Inventor

Beate Kehrel

Martin Brodde

Original Assignee

Hamburger Stiftung Zur Foerder

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-20

Filing date

2001-10-19

Publication date

2008-12-15

2000-10-20 Priority claimed from DE10051983A external-priority patent/DE10051983A1/en

2001-10-02 Priority claimed from DE2001148624 external-priority patent/DE10148624A1/en

2001-10-19 Application filed by Hamburger Stiftung Zur Foerder filed Critical Hamburger Stiftung Zur Foerder

2008-12-15 Application granted granted Critical

2008-12-15 Publication of DK1328289T3 publication Critical patent/DK1328289T3/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Marine Sciences & Fisheries (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)

DK01983562T 2000-10-20 2001-10-19 Oxidized proteins and their biological and therapeutic activity as well as diagnostic use in inhibiting interaction between oxidized proteins and CD36 DK1328289T3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10051983A DE10051983A1 (en)	2000-10-20	2000-10-20	Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36,
DE2001148624 DE10148624A1 (en)	2001-10-02	2001-10-02	Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36,
PCT/EP2001/012129 WO2002032445A2 (en)	2000-10-20	2001-10-19	Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof

Publications (1)

Publication Number	Publication Date
DK1328289T3 true DK1328289T3 (en)	2008-12-15

Family

ID=26007431

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01983562T DK1328289T3 (en)	2000-10-20	2001-10-19	Oxidized proteins and their biological and therapeutic activity as well as diagnostic use in inhibiting interaction between oxidized proteins and CD36

Country Status (14)

Country	Link
EP (2)	EP1994941A3 (en)
JP (1)	JP4881535B2 (en)
AP (2)	AP2781A (en)
AT (1)	ATE406908T1 (en)
AU (1)	AU2002215032A1 (en)
CA (1)	CA2453140C (en)
CY (1)	CY1110418T1 (en)
DE (1)	DE50114289D1 (en)
DK (1)	DK1328289T3 (en)
ES (1)	ES2307662T3 (en)
HK (1)	HK1057857A1 (en)
OA (1)	OA12431A (en)
PT (1)	PT1328289E (en)
WO (1)	WO2002032445A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2523357C (en) *	2003-04-25	2015-07-14	Hamburger Stiftung Zur Foerderung Von Wissenschaft Und Kultur	Treatment of hi-virus infections with oxidised blood proteins
JP5416971B2 (en)	2005-09-16	2014-02-12	コーネルリサーチファウンデイションインコーポレイテッド	Method for reducing the expression of CD36
JP2010235447A (en) *	2007-07-30	2010-10-21	Igaku Seibutsugaku Kenkyusho:Kk	Inhibitory agent for inflammatory cytokine
DE102010043733A1 (en)	2010-11-10	2012-05-10	Oxprotect Gmbh	Unloaded PEGylated liposomes for use as medicaments for the prophylaxis and therapy of hemorrhagic and thromboembolic disorders
DE102011003944A1 (en)	2011-02-10	2012-08-16	Oxprotect Gmbh	Detection and removal of misfolded proteins / peptides
DE102011003936A1 (en)	2011-02-10	2012-08-16	Oxprotect Gmbh	Use of proteins / peptides that bind to GRP78 (BIP) in laboratory methods for monitoring platelet aggregation inhibitors
WO2013082458A1 (en)	2011-12-02	2013-06-06	The Regents Of The University Of California	Reperfusion protection solution and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3819923A1 (en) *	1988-06-11	1989-12-21	Behringwerke Ag	FIBRINE (OGEN) DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
US5192264A (en) *	1989-10-06	1993-03-09	The Beth Israel Hospital Association	Methods and apparatus for treating disease states using oxidized lipoproteins
CA2067364A1 (en) *	1989-10-06	1991-04-07	Eric T. Fossel	Oxidized lipoproteins and methods for their preparation
US5358707A (en) *	1990-01-08	1994-10-25	Schering Corporation	Oxidized variants of GM-CSF
AU8305691A (en) *	1990-07-18	1992-02-18	Beth Israel Hospital Association, The	Method for treating viral infections using oxidized lipoproteins
EP0728019A4 (en)	1993-11-08	1999-07-07	Peptide Delivery Systems Pty L	Labelled diagnostic compositions and methods of their use
RU2089179C1 (en) *	1995-12-14	1997-09-10	Закрытое акционерное общество "ВАМ"	Stimulator of cytokin and hemopoietic factors production and a method of its using
ES2299186T3 (en)	1997-06-20	2008-05-16	LEUVEN RESEARCH & DEVELOPMENT VZW	TESTS, ANTIBODIES AND PATTERNS TO DETECT LIPOPROTEINS OF LOW DENSITY OXIDIZED AND MODIFIED WITH MDA.
GB9806632D0 (en) *	1998-03-28	1998-05-27	Stevenson Robert	Peptide factor
AU1243500A (en) *	1998-11-06	2000-05-29	Emory University	Biomarkers for oxidative stress
DE10045047A1 (en) *	2000-09-12	2002-03-21	Beate Kehrel	Medicament containing activated antithrombin III

2001
- 2001-10-19 PT PT01983562T patent/PT1328289E/en unknown
- 2001-10-19 CA CA2453140A patent/CA2453140C/en not_active Expired - Fee Related
- 2001-10-19 AP AP2009004857A patent/AP2781A/en active
- 2001-10-19 EP EP08012302A patent/EP1994941A3/en not_active Withdrawn
- 2001-10-19 EP EP01983562A patent/EP1328289B1/en not_active Expired - Lifetime
- 2001-10-19 DK DK01983562T patent/DK1328289T3/en active
- 2001-10-19 AU AU2002215032A patent/AU2002215032A1/en not_active Abandoned
- 2001-10-19 ES ES01983562T patent/ES2307662T3/en not_active Expired - Lifetime
- 2001-10-19 AP APAP/P/2003/002795A patent/AP2034A/en active
- 2001-10-19 JP JP2002535683A patent/JP4881535B2/en not_active Expired - Fee Related
- 2001-10-19 AT AT01983562T patent/ATE406908T1/en active
- 2001-10-19 DE DE50114289T patent/DE50114289D1/en not_active Expired - Lifetime
- 2001-10-19 OA OA1200300119A patent/OA12431A/en unknown
- 2001-10-19 WO PCT/EP2001/012129 patent/WO2002032445A2/en active IP Right Grant
2004
- 2004-01-05 HK HK04100053.0A patent/HK1057857A1/en not_active IP Right Cessation
2008
- 2008-11-19 CY CY20081101332T patent/CY1110418T1/en unknown

Also Published As

Publication number	Publication date
CA2453140A1 (en)	2002-04-25
AP2781A (en)	2013-10-31
EP1328289A2 (en)	2003-07-23
AP2003002795A0 (en)	2003-06-30
CY1110418T1 (en)	2015-04-29
WO2002032445A2 (en)	2002-04-25
JP2004511526A (en)	2004-04-15
AP2009004857A0 (en)	2009-06-30
CA2453140C (en)	2016-01-05
DE50114289D1 (en)	2008-10-16
ATE406908T1 (en)	2008-09-15
EP1994941A2 (en)	2008-11-26
EP1328289B1 (en)	2008-09-03
ES2307662T3 (en)	2008-12-01
JP4881535B2 (en)	2012-02-22
PT1328289E (en)	2008-12-10
HK1057857A1 (en)	2004-04-23
AU2002215032A1 (en)	2002-04-29
AP2034A (en)	2009-08-28
OA12431A (en)	2006-04-19
WO2002032445A3 (en)	2003-04-17
EP1994941A3 (en)	2012-07-25

Publication	Publication Date	Title
DE60134866D1 (en)	2008-08-28	USE OF IMIDAZOCHINOLINAMINES AS ADJUVANTIES IN DNA VACCINATION
NO20023043L (en)	2002-08-14	Substituted oxazolidinones and their use in the field of blood coagulation
ATE355022T1 (en)	2006-03-15	SURGICAL SYSTEM WITH HANDLE AND CANNULE
DK1141252T3 (en)	2006-06-19	Human delta-5 desaturase gene and uses thereof
NO324250B1 (en)	2007-09-17	Diazabicyclic compounds, pharmaceutical compositions comprising these and their use
ATE312636T1 (en)	2005-12-15	INFUSION OF LIQUIDS INTO THE HUMAN OR ANIMAL BODY
ID26130A (en)	2000-11-23	IMPROVEMENTS IN MEDICAL INTRODUCTION TOOLS
ID20600A (en)	1999-01-21	GENETIC MODIFIED CELLS AND ITS USE IN PROFILACTIC OR DISEASE THERAPY
NO20021964L (en)	2002-04-25	Biological fluid treatment
PT1017408E (en)	2005-07-29	USE OF TETRA-HYDROLYSTERATIN IN TREATMENT OF TYPE II DIABETES
NO20001905D0 (en)	2000-04-12	Compounds and their use in pharmaceutical or cosmetic preparations
ATA17962001A (en)	2005-12-15	WELLB VERWIND COMFORT AND THERAPY SUPPORT
NO20013102L (en)	2001-08-10	Genes, proteins and their use
DK1328289T3 (en)	2008-12-15	Oxidized proteins and their biological and therapeutic activity as well as diagnostic use in inhibiting interaction between oxidized proteins and CD36
ATE291586T1 (en)	2005-04-15	HUMAN ANTIBIOTIC PROTEIN
DE69526203D1 (en)	2002-05-08	BIOLOGICAL TARGETED AGENTS
PT1178981E (en)	2003-11-28	SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS
NO20030547L (en)	2003-02-04	Azabicyclic derivatives and their therapeutic use
NO20021305D0 (en)	2002-03-15	DNA construction and its use
DK1461042T3 (en)	2008-12-01	Use of desoxypeganine in the treatment of clinical depression
GB2349150B (en)	2001-09-26	Expression of DNA or proteins in C. Elegans
EE200200353A (en)	2003-10-15	Human heparanase-like polypeptide and nucleic acid
NO20030821D0 (en)	2003-02-21	Genes and proteins, and their use
ATE256754T1 (en)	2004-01-15	TANNING/RETANING PREPARATIONS
NO20023003D0 (en)	2002-06-21	Benzophenone glycopyranosides, as well as preparation and therapeutic use